Published in

Royal Society of Chemistry, Nanoscale, 18(14), p. 6735-6742, 2022

DOI: 10.1039/d2nr00664b

Links

Tools

Export citation

Search in Google Scholar

In vitro to in vivo extrapolation to support the development of the next generation risk assessment (NGRA) strategy for nanomaterials

Journal article published in 2022 by Karolina Jagiello ORCID, Krzesimir Ciura ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The in vitro to in vivo extrapolation models (IVIVE) can support the development of the Next Generation Risk Assessment through integration the AOP-anchored strategy for in vitro assays selection with the PBPK models.